<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Presseportal.de - Electrochemotherapy</title><link>https://www.presseportal.de/st/Electrochemotherapy?langid=2</link><description>Presseportal - Deutschlands umfassende Datenbank für Presseinformationen in Text, Bild, Ton und Video - ein Service der dpa-Tochter news aktuell</description><language>de-de</language><copyright>news aktuell GmbH</copyright><image><url>https://www.presseportal.de/images/logos/logo-de-250.jpg</url><title>Presseportal.de - Electrochemotherapy</title><link>https://www.presseportal.de/st/Electrochemotherapy?langid=2</link></image><managingEditor>info@presseportal.de (presseportal.de)</managingEditor><pubDate>Wed, 29 Apr 2026 11:42:21 +0200</pubDate><lastBuildDate>Tue, 28 Apr 2026 11:40:00 +0200</lastBuildDate><category>Electrochemotherapy</category><ttl>6</ttl><atom:link href="https://www.presseportal.de/rss/st/Electrochemotherapy.rss2?langid=2" rel="self" type="application/rss+xml" /><item><title>First Clinical Analysis of Electrochemotherapy in Prostate Cancer Shows 93% Response</title><description>VITUS Privatklinik Prof. Dr. Stehling GmbH: OFFENBACH, Germany (ots) - Vitus Privatklinik reports the first and largest clinical cohort of electrochemotherapy in prostate cancer. Vitus Privatklinik published the first clinical analysis of electrochemotherapy in prostate cancer, involving 144 ...</description><link>https://www.presseportal.de/pm/174468/6264386?langid=2</link><pubDate>Tue, 28 Apr 2026 11:40:00 +0200</pubDate><guid>https://www.presseportal.de/pm/174468/6264386?langid=2</guid>
<content:encoded><![CDATA[<b>VITUS Privatklinik Prof. Dr. Stehling GmbH</b> [<a href="https://www.presseportal.de/pm/174468/6264386?langid=2">Newsroom</a>]<br/>OFFENBACH, Germany (ots) - Vitus Privatklinik reports the first and largest clinical cohort of electrochemotherapy in prostate cancer. Vitus Privatklinik published the first clinical analysis of electrochemotherapy in prostate cancer, involving 144 ... <a href="https://www.presseportal.de/pm/174468/6264386?langid=2">Lesen Sie hier weiter...</a><br clear="all" /><p><small>Original-Content von: VITUS Privatklinik Prof. Dr. Stehling GmbH, übermittelt durch news aktuell</small></p>
]]></content:encoded><category>Gesundheit / Medizin</category><author>info@presseportal.de (presseportal.de)</author><source url="https://www.presseportal.de/pm/174468/6264386?langid=2">VITUS Privatklinik Prof. Dr. Stehling GmbH</source></item></channel></rss>